QMS Medical Allied Services Ltd
Incorporated in 2017, QMS Medical Allied Services Ltd is a manufacturer and distributor of medical devices[1]
- Market Cap ₹ 184 Cr.
- Current Price ₹ 95.3
- High / Low ₹ 110 / 69.0
- Stock P/E 18.2
- Book Value ₹ 53.9
- Dividend Yield 0.52 %
- ROCE 13.2 %
- ROE 10.4 %
- Face Value ₹ 10.0
Pros
Cons
- Company has a low return on equity of 12.0% over last 3 years.
- Promoter holding has decreased over last 3 years: -5.56%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies
Part of Nifty SME Emerge
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| 122 | 156 | 173 | |
| 104 | 130 | 147 | |
| Operating Profit | 18 | 25 | 26 |
| OPM % | 15% | 16% | 15% |
| 0 | 2 | 1 | |
| Interest | 3 | 5 | 7 |
| Depreciation | 3 | 4 | 4 |
| Profit before tax | 12 | 19 | 16 |
| Tax % | 26% | 27% | 27% |
| 9 | 14 | 12 | |
| EPS in Rs | 4.66 | 6.26 | 5.24 |
| Dividend Payout % | 0% | 0% | 10% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -16% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -13% |
| 1 Year: | 12% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 12% |
| Last Year: | 10% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Equity Capital | 18 | 18 | 19 |
| Reserves | 61 | 72 | 85 |
| 35 | 60 | 68 | |
| 22 | 40 | 41 | |
| Total Liabilities | 135 | 190 | 213 |
| 24 | 53 | 57 | |
| CWIP | 2 | 3 | 0 |
| Investments | 2 | 3 | 5 |
| 108 | 131 | 150 | |
| Total Assets | 135 | 190 | 213 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| 1 | 20 | 19 | |
| -3 | -45 | -20 | |
| 0 | 26 | 1 | |
| Net Cash Flow | -1 | 1 | 0 |
| Free Cash Flow | 1 | 20 | 19 |
| CFO/OP | 26% | 101% | 93% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Debtor Days | 124 | 101 | 142 |
| Inventory Days | 172 | 176 | 181 |
| Days Payable | 90 | 76 | 73 |
| Cash Conversion Cycle | 205 | 202 | 250 |
| Working Capital Days | 148 | 100 | 105 |
| ROCE % | 17% | 13% |
Insights
In beta| Mar 2024 | Mar 2025 | |
|---|---|---|
| Number of B2B Health Camps Number |
|
|
| Number of Cities Presence Number |
||
| Number of Employees (Total Workforce) Number |
||
| Number of Healthcare Professionals (HCPs) Engagement Lakhs |
||
| Number of Institutional Clients Number |
||
| Number of Patient Service Programs (PSPs) Number |
||
| Number of Patients Tracked in Digital Ecosystem Lakhs |
||
| Number of SKUs Number |
||
| Serviceable Pin Codes Number |
||
Extracted by Screener AI
Documents
Announcements
-
Analysts/Institutional Investor Meet/Con. Call Updates
10 June 2026 - FY26 earnings call transcript: revenue INR172.9 crore, PAT INR11.9 crore, services growth guidance reiterated.
-
Disclosure under SEBI Takeover Regulations
5 June 2026 - Company filed promoters’ Regulation 31(4) disclosure under SEBI takeover regulations.
-
Analysts/Institutional Investor Meet/Con. Call Updates
4 June 2026 - Audio recording uploaded for FY26 audited results earnings call held June 4, 2026.
-
General Updates
4 June 2026 - Board approved FY26 audited results, Rs0.50 dividend, internal auditor reappointment, and NSE Emerge migration IM.
-
Analysts/Institutional Investor Meet/Con. Call Updates
4 June 2026 - QMS Medical released Q4/FY26 investor presentation; FY26 revenue rose 11% to ₹172.9 crore, PAT fell 13% to ₹11.9 crore.
Annual reports
Concalls
-
Jun 2026TranscriptPPT
-
Feb 2026TranscriptAI SummaryPPT
-
Nov 2025Transcript PPT
-
Aug 2025TranscriptPPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Sep 2023Transcript PPT
Business Overview:[1]
QMASL does marketing and distribution of medical products and medical education services to clinics, pharma, medical companies and also to individual users. These devices are sold directly in the brand of the manufacturer and are sold under the brand name Q Devices. Company manages the distribution for other brands viz. 3M, Heine, Rossmax, etc.